16.92
price down icon7.89%   -1.45
after-market Dopo l'orario di chiusura: 17.00 0.08 +0.47%
loading
Precedente Chiudi:
$18.37
Aprire:
$18.67
Volume 24 ore:
319.99K
Relative Volume:
17.74
Capitalizzazione di mercato:
$761.05M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+0.00%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
Value
$16.21
$18.84
Intervallo di 1 settimana:
Value
$15.00
$18.84
Portata 52W:
Value
$15.00
$18.84

Maplight Therapeutics Inc Stock (MPLT) Company Profile

Name
Nome
Maplight Therapeutics Inc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
MPLT's Discussions on Twitter

Confronta MPLT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MPLT
Maplight Therapeutics Inc
16.92 761.05M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Maplight Therapeutics Inc Borsa (MPLT) Ultime notizie

pulisher
Oct 31, 2025

MapLight Therapeutics, Inc. (MPLT) Stock Major Holders - Yahoo! Finance Canada

Oct 31, 2025
pulisher
Oct 31, 2025

Finance Watch: MapLight Brings US Biopharma IPO Tally To 11 In 2025 - Citeline News & Insights

Oct 31, 2025
pulisher
Oct 31, 2025

MapLight Therapeutics Closes Successful IPO and Private Placement - MSN

Oct 31, 2025
pulisher
Oct 30, 2025

Major Investment Alert: A S Novo’s Multi-Million Dollar Bet on MapLight Therapeutics! - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Drug developer Evommune to go public next week, following MapLight's successful IPO - The Business Journals

Oct 30, 2025
pulisher
Oct 30, 2025

Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

MapLight Therapeutics completes $296 million IPO on nasdaq - Investing.com

Oct 30, 2025
pulisher
Oct 29, 2025

Catalyst4, Inc. Makes a Major Move with a Massive Stock Purchase in MapLight Therapeutics! - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Latest Stock News & Headlines - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Stock Forum & Discussion - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics, Inc. (MPLT) Interactive Stock Chart - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics completes $296 million IPO on nasdaq By Investing.com - Investing.com Nigeria

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times

Oct 29, 2025
pulisher
Oct 29, 2025

MapLight Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares - Benzinga

Oct 29, 2025
pulisher
Oct 28, 2025

Total liabilities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Diluted earnings per share (diluted EPS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Revenue Breakdown – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total liabilities & shareholders' equities of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Operating income of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Net debt of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Operating expenses (excl. COGS) of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Taxes of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Financial Statements – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total revenue of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Total operating expenses of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Gross profit of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

After tax other income/expense of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Earnings and Revenue – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

EBITDA margin % of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Balance Sheet – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Non-controlling/minority interest of MapLight Therapeutics, Inc. – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

Muscarinic path still charting as Maplight IPO gets $258M - BioWorld MedTech

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Income Statement – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. Statistics – NASDAQ:MPLT - TradingView

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. (MPLT) Valuation Measures & Financial Statistics - Yahoo! Finance Canada

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. (MPLT) Company Profile & Facts - Yahoo! Finance Canada

Oct 28, 2025
pulisher
Oct 28, 2025

MPLT: Static price chart | MapLight Therapeutics, Inc. | US56565P1030 - MarketScreener

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics announces pricing of IPO - The Pharma Letter

Oct 28, 2025
pulisher
Oct 28, 2025

Sergey Brin nonprofit gets $261 million lift in MapLight IPO - Crain Currency

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight shares track up after $251m IPO - pharmaphorum

Oct 28, 2025
pulisher
Oct 28, 2025

MapLight Therapeutics, Inc. (MPLT) Options Chain - Yahoo! Finance Canada

Oct 28, 2025
pulisher
Oct 28, 2025

Latham & Watkins Advises on MapLight Therapeutics’ Initial Public Offering - Legal Desire Media and Insights

Oct 28, 2025
pulisher
Oct 27, 2025

MapLight Therapeutics, Inc.(NasdaqGS: MPLT) added to NASDAQ Composite Index - MarketScreener

Oct 27, 2025
pulisher
Oct 27, 2025

MapLight Therapeutics Inc. (MPLT): Oversubscribed Neuroscience IPO Launches with a Bright Start - Smartkarma

Oct 27, 2025
pulisher
Oct 27, 2025

Sergey Brin Nonprofit Gets a $242 Million Lift From MapLight IPO - Bloomberg.com

Oct 27, 2025
pulisher
Oct 27, 2025

Sergey Brin Nonprofit Gets $261 Million Lift in MapLight IPO (2) - Bloomberg Law News

Oct 27, 2025
pulisher
Oct 27, 2025

Biotech MapLight Jumps 23% in First US IPO Using Shutdown Fix - Bloomberg.com

Oct 27, 2025
pulisher
Oct 27, 2025

Biotech Firm MapLight Inks $251M IPO Amid Shutdown - Law360

Oct 27, 2025
pulisher
Oct 27, 2025

MapLight Therapeutics raises $258M in IPO, private placement - Axios

Oct 27, 2025
pulisher
Oct 27, 2025

CNS drug developer MapLight goes public, stock up 9% on first day of trading - The Business Journals

Oct 27, 2025
pulisher
Oct 27, 2025

Novo-backed MapLight valued at $787 million after shares jump in Nasdaq debut - Yahoo Finance

Oct 27, 2025

Maplight Therapeutics Inc Azioni (MPLT) Dati Finanziari

Non sono disponibili dati finanziari per Maplight Therapeutics Inc (MPLT). Controlla altri titoli per ulteriori informazioni.

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):